ATE146474T1 - Imidazoindolizinderivate mit angiotensin-ii hemmwirkung - Google Patents

Imidazoindolizinderivate mit angiotensin-ii hemmwirkung

Info

Publication number
ATE146474T1
ATE146474T1 AT92114987T AT92114987T ATE146474T1 AT E146474 T1 ATE146474 T1 AT E146474T1 AT 92114987 T AT92114987 T AT 92114987T AT 92114987 T AT92114987 T AT 92114987T AT E146474 T1 ATE146474 T1 AT E146474T1
Authority
AT
Austria
Prior art keywords
imidazoindolizine
angiotensin
substituted
inhibiting effect
derivatives
Prior art date
Application number
AT92114987T
Other languages
English (en)
Inventor
Yasushi Honma
Yasuo Sekine
Sumihiro Nomura
Kazuaki Naito
Hiroshi Narita
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE146474T1 publication Critical patent/ATE146474T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT92114987T 1991-09-10 1992-09-02 Imidazoindolizinderivate mit angiotensin-ii hemmwirkung ATE146474T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30856091 1991-09-10
JP5304492 1992-01-27

Publications (1)

Publication Number Publication Date
ATE146474T1 true ATE146474T1 (de) 1997-01-15

Family

ID=26393753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92114987T ATE146474T1 (de) 1991-09-10 1992-09-02 Imidazoindolizinderivate mit angiotensin-ii hemmwirkung

Country Status (16)

Country Link
US (1) US5268377A (de)
EP (1) EP0531876B1 (de)
JP (1) JP2590797B2 (de)
KR (1) KR0168457B1 (de)
AT (1) ATE146474T1 (de)
AU (1) AU644539B2 (de)
CA (1) CA2077420C (de)
DE (1) DE69216013T2 (de)
DK (1) DK0531876T3 (de)
ES (1) ES2098403T3 (de)
FI (1) FI98369C (de)
GR (1) GR3022106T3 (de)
ID (1) ID902B (de)
IL (1) IL103021A (de)
MY (1) MY129927A (de)
SG (1) SG42962A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06271576A (ja) * 1993-03-19 1994-09-27 Upjohn Co:The イミダゾール誘導体の製法
FR2712592B1 (fr) * 1993-11-17 1995-12-22 Adir Nouveaux dérivés tricycliques azotés, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP2527360B1 (de) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Für die Behandlung von gastrointestinalen Erkrankungen, Entzündungen, Krebs und anderen Erkrankungen geeignete Agonisten von Guanylatcyclase
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
AU2017289974B2 (en) 2016-06-29 2021-08-12 Bristol-Myers Squibb Company Biarylmethyl heterocycles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1047148A1 (ru) * 1981-03-30 1986-12-23 Институт физико-органической химии и углехимии АН УССР Бензилиденпроизводные имидазо-[4,5-L]-индолизинов,обладающие бактериостатической и фунгистатической активностью
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
US4812462A (en) * 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
US4816463A (en) * 1986-04-01 1989-03-28 Warner-Lambert Company Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
MY129927A (en) 2007-05-31
CA2077420C (en) 1998-08-25
IL103021A0 (en) 1993-02-21
EP0531876A3 (de) 1993-05-05
EP0531876A2 (de) 1993-03-17
AU644539B2 (en) 1993-12-09
IL103021A (en) 1996-10-16
CA2077420A1 (en) 1993-03-11
FI98369C (fi) 1997-06-10
KR930006024A (ko) 1993-04-20
FI924043A0 (fi) 1992-09-10
JP2590797B2 (ja) 1997-03-12
US5268377A (en) 1993-12-07
KR0168457B1 (ko) 1999-01-15
SG42962A1 (en) 1997-10-17
JPH05279365A (ja) 1993-10-26
FI924043A (fi) 1993-03-11
DE69216013T2 (de) 1997-05-07
DK0531876T3 (de) 1997-02-17
EP0531876B1 (de) 1996-12-18
AU2205692A (en) 1993-03-11
ID902B (id) 1996-09-09
ES2098403T3 (es) 1997-05-01
DE69216013D1 (de) 1997-01-30
FI98369B (fi) 1997-02-28
GR3022106T3 (en) 1997-03-31

Similar Documents

Publication Publication Date Title
GB9625045D0 (en) Parasiticidal compounds
NZ514873A (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
ES2187561T3 (es) Derivados heterobiciclicos.
ATE146474T1 (de) Imidazoindolizinderivate mit angiotensin-ii hemmwirkung
WO2001038324A3 (en) Imidazole derivatives and their use as raf kinase inhibitors
MXPA05012415A (es) Inhibidores de glutamina fructosa-3-fosfato amidotransferasa (gfat).
ES2122289T3 (es) Derivados de 5-arilindol.
NZ535267A (en) Benzofuran derivatives as inhibitors of blood coagulation factor X
NO944371D0 (no) Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning
AU6948091A (en) Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use
UA27713C2 (uk) Амідинові похідні бензолу, що мають гіпоглікемічну активність, та їх фармацевтично прийнятні солі
DE69916066D1 (de) Neue benzoxazole mit pde-hemmender wirkung
AU615385B2 (en) Heterocyclicgaunidines as 5ht antagonists
DK0682023T3 (da) Imidazopyridinderivater og fremgangsmåde til fremstilling deraf

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee